Application 206917
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | LINEZOLID | LINEZOLID | SOLUTION;INTRAVENOUS | 600MG/300ML (2MG/ML) | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 55150-242 | Linezolid | Linezolid | AuroMedics Pharma LLC | ANDA | Current |
| 55150-242 | Linezolid | Linezolid | AuroMedics Pharma LLC | ANDA | Current |
| 55150-242 | Linezolid | Linezolid | AuroMedics Pharma LLC | ANDA | Current |
| 55150-242 | Linezolid | Linezolid | AuroMedics Pharma LLC | ANDA | Current |
| 55150-242 | Linezolid | Linezolid | AuroMedics Pharma LLC | ANDA | Current |
| 55150-242 | Linezolid | Linezolid | AuroMedics Pharma LLC | ANDA | Current |
| 55150-242 | Linezolid | Linezolid | AuroMedics Pharma LLC | ANDA | Current |